james q. del rosso, do, faocd

of 31

JAMES Q. DEL ROSSO, DO, FAOCD Dermatology, Cutaneous Surgery,

Education & Clinical Research Las Vegas, Nevada

Email: [email protected] Cell Phone: 702-596-6137

Primary Contact Information James Q. Del Rosso DO, LLC Direct Performance of Services and/or Consultative Services in Clinical Research, Educational Programs, and Publications in Dermatology Over 20 years of experience nationally and internationally; has served as Principal Investigator in multiple studies; lead author of multiple study publications.

Administrative Office and 8644 Castle Hill Avenue Mailing Address: Las Vegas, Nevada 89129 Email: [email protected] Phone (cell): 702-596-6137 Research Center Del Rosso Dermatology Research Mailing Address: 8861 W. Sahara Avenue Suite 230 Las Vegas, Nevada 89117 Email: [email protected] Phone (Research Center): 702-331-4123 Phone (Melissa Jacobson, CRC) 702-964-2425 Phone (Dr. Del Rosso) 702-596-6137

Dermatology Private Practice James Q. Del Rosso, DO (JDRx Dermatology, LLC) Private Dermatology Practice Private practice in medical dermatology (children and adults), dermatologic surgery, and Mohs micrographic surgery. Twenty-eight years of clinical practice experience since 1986 (Ohio, 5 years; Florida, 5 years; Nevada, 19 years.

Lakes Dermatology 8861 W Sahara Avenue Clinic Address: Suite 290 Las Vegas, Nevada 89117 Phone: 702-869-6667 (for patient appointments only)

Dermatology Research

mailto:[email protected]


of 31

Del Rosso Dermatology Research / James Q. Del Rosso, DO, LLC Principal Investigator and Other Services in Clinical Dermatology Research James Q. Del Rosso DO (Principal Investigator) Over 20 years of experience in clinical research in dermatology; consultation on study design, protocol design, data analysis, and manuscript preparation and review; investigator-initiated studies, experience with investigator training; photographic documentation; cases study projects. All research studies and case study/observational projects carried out in accordance with recognized research standards, regulations, documentation, and proper informed consent. Past study areas: acne, rosacea, eczema (including atopic dermatitis), psoriasis (topical and systemic therapy), actinic keratosis, fungal infections, herpes zoster infection, herpes simplex infection, seborrheic dermatitis, epidermal barrier repair.

Contact Information: Melissa Jacobson CRC (Administrative Director) [email protected]; 702-964-2425

Dr. Del Rosso: [email protected] ; 702-596-6137 (cell phone)

Administrative Address: 8644 Castle Hill Avenue Las Vegas, Nevada 89129 Study Site: Del Rosso Dermatology Research (at Lakes Dermatology) 8861 W Sahara Avenue Suite 230 Las Vegas, Nevada 89117

Personal Information Born February 16, 1954 in Brooklyn, New York Parents deceased, 1 sister (Marilyn Lanza) Married to Karyn Del Rosso 3 children (Chrystyna, Jaclyn, Ron), 6 grandchildren (Ari, Britney, Allyson, Blake, Emily, Asher), 2 great grandchildren (Christy Paige, Kourtney) Hobbies: music, avid music and guitar collector, sports, avid sports collector

Educational Background

Undergraduate Education

St. John’s University College of Pharmacy Jamaica, New York Bachelor of Science in Pharmacy (Class of 1976) Pharmacy Residency Education


of 31

Temple University Hospital Department of Pharmacy Philadelphia, Pennsylvania Hospital Pharmacy Residency (1976-1977)

Medical School Education Ohio University College of Osteopathic Medicine Athens, Ohio (Class of 1982) Graduated Cum Laude Rotating Internship Doctors Hospital Columbus, Ohio (1982-1983) Dermatology Residency and Fellowship Training Dermatology Residency Atlantic Skin Disease Associates/Doctors Hospital Fort Lauderdale, Florida (1983–1986) Program Director: David C Horowitz, DO Mohs Micrographic Surgery and Cutaneous Oncology Fellowship Ohio State University Arthur James Hospital Columbus, Ohio (1990-1991) Program Director: Ronald J Siegle, MD

Professional Employment Current Practice Employment Last Vegas Skin and Cancer Clinics/West Dermatology Henderson, Nevada and Las Vegas, Nevada (1997 – current) Past Practice Employment Ohio University College of Osteopathic Medicine Athens, Ohio (1986-1990) Assistant Professor (Dermatology) in Section of Internal Medicine Assistant Director, Medical Center Clinic Dermatology Course Director

of 31

West Florida Medical Center Clinic Pensacola, Florida (1994-1996) Dermatology, Cutaneous Surgery, and Mohs Micrographic Surgery Director, Dermatology Laboratory/Mohs Micrographic Surgery Laboratory Honorary Award 1994, West Florida Medical Center Academic Honor Society Board of Directors, West Florida Medical Center Clinic

Board Certifications Board certified in Dermatology (1988) Certificate of Added Qualification (CAQ) in Mohs micrographic surgery (1995)

Medical Licensure Nevada #466 (DO) Since April 1989 (actively practicing in Nevada since 1996) Arizona (DO) Since October 1996 (not actively practicing in Arizona) Ohio (DO) Since April 1986 (original practice license, not actively

practicing in Ohio)

Academic Affiliations Clinical Professor (Dermatology) Adjunct Clinical Faculty Touro University College of Osteopathic Medicine Henderson, Nevada (2005 – present) Chief Instructor of Dermatology Course Clinical Preceptor (clinic rotations for third and fourth year medical students) Touro University College of Osteopathic Medicine Henderson, Nevada (2005 – present) Dermatology Residency Program Director* Valley Hospital Medical Center Las Vegas, Nevada Touro University College of Osteopathic Medicine Henderson, Nevada (2005-2013) (*program discontinued by hospital in July 2013 due to lack of funding)

Professional Society Memberships and Activities Memberships

of 31

American Academy of Dermatology (AAD) American Osteopathic College of Dermatology (AOCD) American Acne and Rosacea Society (AARS) American Dermatologic Association (ADA) Council for Nail Disorders (CND) National Society of Cutaneous Medicine (NSCM) American Osteopathic Association (AOA) American Society for Dermatologic Surgery (ASDS) American College of Mohs Micrographic Surgery (ACMS) American Society for Mohs Surgery (ASMS) Nevada Osteopathic Medical Association (NOMA) Dermatology Society Leadership Positions Past-President American Acne and Rosacea Society (2009 – 2011) Past-President American Osteopathic College of Dermatology (1993 - 1994) Annual Meeting Program Chairman (1993) Past President Council for Nail Disorders (2006 - 2008) Past President American Society for Mohs Surgery (2005) Society Board Positions Board Member American Osteopathic Board of Dermatology (AOBD) (1999-2010) Reviewing and revising when warranted criteria for dermatology board certification; preparing

board certification examination; overseeing the certification process for dermatologist trained

under the American Osteopathic Association. Overall board responsibility and with

designated responsibility as co-director of section involving preparation of case study

questions with clinical photographs (visual recognition)

Board of Directors (2012-present) National Society of Cutaneous Medicine Board of Directors Council for Nail Disorders (CND) (from inception through 2003)

of 31

Board of Directors American Acne and Rosacea Society (AARS) (2005 – 2009; 2013 - present) Board of Directors American Society for Mohs Surgery (ASMS) (1998 – 2005)

Society Committee Activities Education Committee, Chairman American Acne and Rosacea Society (AARS) (2009 – present) Education Committee, Member American Acne and Rosacea Society (AARS) (2007 – 2009) Environment and Drugs Committee Chairman American Academy of Dermatology (AAD) (2007 – 2010) FDA Liaison Task Force American Academy of Dermatology (2003 – 2004)

Publication Affiliations Journal of Clinical and Aesthetic Dermatology (JCAD) Editor-In-Chief (Clinical Dermatology) 2007 (start of journal – present) Textbook Editor Shalita AR, Del Rosso JQ, Webster GF. Editors, Acne Vulgaris, informaHealth, London, UK and New York, NY, 2011 Cutis Drug Therapy Topics Section Founder and Author Editorial Board for peer review Journal of Drugs in Dermatology (JDD) Guest Editor, Annual Acne & Rosacea Issue (2007 – present) Editorial Board for peer review Yearbook of Dermatology and Dermatologic Surgery* Editor (2009-2012) (*last published in 2012, hard copy publications discontinued by publisher)

Dermatologic Clinics Guest Editor

of 31

Drug Actions, Reactions and Interactions (April 2007) Antibiotic Use in Dermatology (January 2009) Acne (in development, Guest Co-Editor) American Acne and Rosacea Society Ad Hoc Rosacea Projects Project Director: Guidelines on Management of Rosacea publication (2007-2008; publication in Journal of Drugs in Dermatology) Project Director: Understanding Pathophysiologic Mechanisms in Rosacea and Correlation with Therapy (Meeting in Boston, MA August 2012; publication as supplement in Cutis March 2013) Project Director: Current Recommendations from AARS on Management of Rosacea (5-part article series published in Cutis November 2013 – March 2014) American Acne and Rosacea Society Pediatric Acne Ad Hoc Project Evidence-based Recommendations for the Diagnosis and Treatment of Pediatric Acne (meeting in 2011 followed by publication in Pediatrics in 2013; endorsed by the American Academy of Pediatrics accepting the guidelines as their policy) Project member: review of all section, presentation and emphasis on oral and topical antibiotic use for acne in pediatric patients American Acne and Rosacea Society Acne in Adult Women Ad Hoc Project Project Director: project in progress (2014- 2015) Dermatology Therapeutic Update: An Informational Newsletter for Pediatricians Newsletter Editor and Co-Author (2008-2009) Pathways: Practical Career Advice for Dermatology Residents Newsletter Editor and Co-Author (2004 – 2008) Extensions: An Educational Newsletter for Physician Assistants and Nurse Practitioners in Dermatology Newsletter Co-Editor and Co-Author (2004-2008) Current Clinical Concepts: A Panoramic View of Literature of Significance to Dermatology Newsletter Co-Editor and Co-Author (2006)

National and International Dermatology Meeting Directorships and Affiliations International Symposium on Acne and Rosacea Monaco, France (May 2014) Chairman and Speaker

of 31

Speaker: Correlation of the Pathophysiology of Rosacea with Management Speaker: Translation of Newer Information on Pathophysiology and Inflammation with the Optimization of Therapeutic Approaches in Acne Moderator: Antibiotic Resistance Issue and their Relationship to the Dermatologist Moderator: Pathophysiology of Rosacea / Rosacea Management Moderator: Pathophysiology of Acne / Acne Management Fall Clinical Dermatology Las Vegas, Nevada (October 2001-present) Program Co-Director and Speaker Speaker: What’s New in The Medicine Chest? Part 1 and Part 2 (each year) Advances in Onychomycosis Therapy (2013) Scientific Poster Review (2010 – present) Winter Clinical Dermatology Hawaii, USA (2008-present) Program Co-Director and Speaker What’s New in the Medicine? Part 1 and Part 2 (each year) Therapeutic Update (2014) Update on Relevance of Epidermal Barrier in Health and Disease (2012) Scientific Poster Review (2010 – present) American Academy of Dermatology Annual Winter and Summer Meetings Speaker and Session Director at multiple meetings (1995-present) Acne and Rosacea Symposum (multiple years) Controversies in Dermatology (multiple years) Oral Isotretinoin Update (2014) Antibiotic Use in Acne and Rosacea (multiple years) Therapeutic Update (multiple years) Forum on Nail Disease (2003, 2004) Management of Onychomycosis and Cutaneous Fungal Inections (multiple years) Update on Pathophysiology and Treatment of Rosacea (multiple years) So Many Drugs, So Little Time (multiple years) Drug Interactions of Significance to Dermatologists Session (multiple years) Safety of Topical Therapies Used in Dematology (2013) Oral Spironolactone Use in Adult Women with Acne (2013) Topical Anti-inflammatory Therapies (2013, 2014) Actinic Keratoses and Non-Melanoma Skin Cancers (multiple years) Alabama Dermatology Society Seminar in the City New York, NY (May 2014) Speaker Face to Face with Acne and Rosacea

of 31

Alabama Dermatology Society Summer Seminar San Destin, Florida (2006 - 2010, 2013 – present) Speaker So Many Drugs, So Little Time (multiple years) Acne and Rosacea (multiple years) Advances in the Management of Onychomycosis (2014) Acne in the Adult Female (2013) Management of Actinic Keratosis (2013) Antibiotic Resistance: Is It Real and How Does It Impact on Dermatology? (2013) Hot Topics: Minocycline vs Doxycycline (2012) Open Forum: Clinical Tips, Questions and Answers (multiple years) Seminar at Sea Speaker (2008-present) Drug Actions, Reactions, and Interactions Acne, Rosacea, Eczema, Psoriasis and Other Common Dermatoses So Many Drugs, So Little Time: Therapeutic Update Clinical Pearls Real World Dermatology for Dermatology Residents Las Vegas, Nevada (2011-present) Program Co-Director and Speaker What You Need To Know: Acne and Rosacea (speaker) What You Need To Know: Acne and Rosacea (speaker) Actinic Keratosis Diagnosis and Management (2013, speaker) South Beach Annual Symposium Miami Beach. Florida (2006-present) Medical Dermatology Session Co-Director, Moderator and Speaker Presentations on acne vulgaris, rosacea, atopic dermatitis/eczematous dermatitis, psoriasis, antibiotic therapy, topical immunomodulator therapy, epidermal barrier therapies, actinic keratosis, non-melanoma skin cancer, fungal infections, viral infections, bacterial infections DERM 2014 Las Vegas, Nevada (July 2014) Clinical Program Co-Director and Speaker Program for Dermatology Physician Assistance and Nurse Practitioners Speaker: Antibiotic Stewardship in Dermatology Co-Speaker: Diagnosis and Management Onychomycosis with Review of Advances in Topical Management Speaker: Management of Actinic Keratoses

of 31

Co-Speaker: Medical Therapies for Acne Vulgaris Speaker: Understanding the Clinical Relevance of Barrier Scientific Panel on Antibiotic Use in Dermatology (SPAUD) Las Vegas, Nevada (2006-present) Program Founder, Chairman, Moderator, and Speaker Meeting (April 2006) and supplement publication in Cutis (June 2007); poster and newsletter Meeting (November 2007) and supplement publication in Cutis (August 2008); poster, newsletter Meeting under AARS (September 2014); other initiatives in development Rosacea International Study Group (RISG) Annual Meeting Member and Speaker (2009-present) Multiple locations (New York, N, USA; Chicago, Illinois, USA; Berlin, Germany; Dublin, Ireland; Bourdeaux, France) Presentations: subantimicrobial therapy, pathophysiology and management of rosacea, causes of erythema of rosacea and correlation with management, natural history and progression of rosacea, observation and challenges with topical alpha-adrenergic therapy in rosacea Publication of supplement in Journal of American Academy of Dermatology (December 2013) American Podiatric Medical Association Annual Meeting Speaker: Management of Cutaneous Fungal Infections Las Vegas, NV (August 2013) Speaker: Antifungal Therapy Update; Clinically Significant Drug Interactions Boston (August 2004) Speaker: Safety of Oral Antifungal Agents Philadelphia, PA (August 2000) Scientific Advisory Panel on Maintenance of the Structural and Functional Integrity of the Skin: Focus on the Physiology and Pathophysiology of the Stratum Corneum and Epidermal “Barrier” in Healthy and Diseased Skin Las Vegas, Nevada (April 2011 meeting; subsequent publications) Program Director, Founder, and Speaker Speaker: What is the “Epidermal Barrier”? What Are It’s Functions? Speaker: Stratum Corneum Barrier Structure and Function in Health and Diseases Skin Seven publications followed related to this project in Journal of Clinical and Aesthetic Dermatology with multiple authors on stratum corneum structure and function in normal skin, compromised skin, and diseases skin: role of Raman spectroscopy; effect of topical corticosteroid on barrier functions; the epidermal barrier in acne vulgaris, effects

of 31

of oral isotretinoin on the stratum corneum and barrier structure and functions; 3-part article series on atopic dermatitis and the epidermal barrier. Mount Sinai Medical Center Annual Dermatology Update Meeting New York, New York (2007 – present) So Many Drugs, So Little Time (multiple years) What’s New in the Medicine Cabinet? (multiple years) Drug Development in Dermatology: Where Are We Now? (2012) American Osteopathic College of Dermatology Annual and Midyear Meetings Speaker, Session Director, Course Director (1993 – present) Onychomycosis: What Is New in Diagnosis and Management? (2014) Status Report on Actinic Keratosis Diagnosis and Management (2013, 2014) Therapeutic Update (multiple years) So Many Drugs, So Little Time (multiple years) Proper Utilization of Biopsy Techniques for Pigmented Skin Lesions (multiple years) Cases About Faces (multiple years) Hair & Nails & Ant-Aging Speaker Capri, Italy (2012-2013) So Many Drugs, So Little Time: What Does the Dermatologist Need to Know to Improve Treatment Outcomes (May 2013) Connecting the Dots Between the Pathogebesis & Management of Rosacea (May 2013) The Functional and Structural Integrity of the Stratum Corneum: Relevance to Skin Health and Disease (May 2012) Status Report on Acne and Rosacea (May 2012) Ohio Dermatological Association 30th Annual Meeting Speaker Columbus, Ohio (October 2013) Four-Hour Dermatology Teaching Session for Residents (Ohio State University, Case Western) Ohio University, Cleveland Clinic, Cuyahoga Falls) So Many Drugs, So Little Time: A Therapeutic Update Las Vegas Dermatology Seminar Speaker Las Vegas, Nevada (October 2013) Great Cases from the Las Vegas Dermatology Society (multi-speaker session) Dermatology Symposium for Private Practice Dermatologists in Italy Speaker

of 31

Pugniochuso, Italy (May 2013) Status Report on the Management of Rosacea Dermatology Update 2012 Speaker Vancouver, Canada (October 2013) Speaker Inflammation in the Pathogenesis of Acne: What Is The Clinical Relevance? Why Is Skin Care So Important To You? Managing the Erythema of Rosacea: What Do We Know About Topical Brimonidine? Connecting the Dots in Acne & Rosacea European Academy of Dermatology and Venereology 21st Annual Congress Prague, Czechoslovakia (September 2012) Program Co-Chairman and Speaker No More Red Symposium Speaker: Connecting the Dots in Rosacea Moderator and Panelist: Open Panel Discussion Skin Curriculum Overview for Physician Extenders (Annual SCOPE Course)* Program Co-Director and Co-Founder Multiple cities (2004-2010) (*annual core curriculum national meeting for physician assistants and nurse practitioners employed and/or supervised by dermatologists in dermatology practices) North American Clinical Dermatology Society Dublin, Ireland (July 2008) Speaker Status Report on Acne and Rosacea Drug Actions, Reactions & Interactions Dermatology Foundation Clinical Symposium Amelia Island, Florida (April 2008) Speaker Topical Barrier Repair Creams: What Are They & What Do They Do? Dermatology All That Jazz Meeting Tulane University Department of Dermatology Speaker So Many Drugs, So Little Time: A Therapeutic Update (April 2008) What’s New in the Medicine Cabinet for Acne & Rosacea? (April 2008) Update on Rosacea and Acne (April 2001)

of 31

World Congress of Dermatology Buenos Aires, Argentina (October 2007) Speaker Antibiotic Resistance: Issues of Significance to Dermatology Florida Society of Dermatology and Dermatologic Surgery West Palm Beach, Florida (May 2007) Speaker Drug Actions, Raections & Interactions Acne Update/iPledge Update New Mexico Dermatology Society Albuquerque, New Mexico (April 2007) Speaker Therapeutic Update Update on Antibiotic Therapy Taiwan Dermatology Society Kaohsiung City, Taiwan (May 2006) Speaker Update on Acne Vulgaris Utah Dermatological Association Springdale, Utah (May 2004) Speaker Antibiotic Therapy Drug Actions, Reactions & Interactions Cleveland Clinic Foundation Dermatology Department Cleveland, Ohio (March 2004) Speaker Update on Antibiotic Therapy in Dermatology Pacific Dermatology Association Las Vegas, Nevada (August 2003) Program Chairman and Speaker Therapeutic Potpourri Medical Management of Cutaneous Epithelial Malignancy Council for Nail Disorders Washington, DC (March 2001) Program Co-Director

of 31

Illinois Podiatric Medical Association Convention Chicago, Illinois (September 2000) Speaker

Onychomycosis in Special Populations Regional Congress of Dermatology Kuala Lumpur, Malaysia (July 2000) Antifungal Therapy Update Baja Crippled Children Podiatry Project Los Angeles, California Speaker Dermatologic Disorders of Interest to the Podiatrist (January 2001) Podiatric Dermatology: A Case Study Review (January 2000) Dermatology Grand Rounds Invited Guest Faculty University of Naples, Italy Department of Dermatology 2013 Harbor UCLA Medical Center Dermatology 2013 Penn State University Hershey Medical Center Department of Dermatology 2012 Ohio State University Department of Dermatology 2012 St. Lukes/Roosevelt Hospital, New York Department of Dermatology 2012 University of Miami Department of Dermatology 2011 Mount Sinai Medical Center, New York Department of Dermatology 2010 University of California Irvine 2009 Cleveland Clinic Foundation Department of Dermatology 2008, 2004 Loma Linda University Department of Dermatology 2006, 2000 University of Oklahoma Department of Dermatology 2005 University of Tennessee Department of Dermatology 2005 University of Bologna, Italy Department of Dermatology 2003, 2004 Louisiana State University Medical Center 1996

Publications

Textbook Chapters

Kim S, Michaels BD, Kim GK, Del Rosso JQ. Systemic antibacterial agents. In: Wolverton SE, Ed. Comprehensive Dermatologic Drug Therapy, 3rd Edition, El;sevier-Saunders, Philadelphia, PA, USA. 2013, pp 61-97. (served as senior author overseeing entire chapter; wrote the introductory section, the tetracyclines section, and the macrolides section) Del Rosso JQ. Topical antibiotics. In: Shalita AR, Del Rosso JQ, Webster GF. Eds, Acne Vulgaris, informaHealth, London, UK and New York, NY, 2011, pp 95-104.

of 31

Del Rosso JQ. Oral antibiotics. In: Shalita AR, Del Rosso JQ, Webster GF. Eds, Acne Vulgaris, informaHealth, London, UK and New York, NY, 2011, pp 113-124. Williams V, Rosen T, Ceilley R, Del Rosso JQ, Stockfleth E. Topical treatment of skin cancer. In: Rigel DS, Robinson JK, Ross M, Friedman RJ, Cockerell CJ, Lim HW, Stockfleth E, Kirkwood JM, Eds, Cancer of the Skin, 2nd Edition, Elsevier-Saunders, Philadelphia, PA, USA. 2011, pp 462-476. Ceilley RI, Del Rosso JQ. Topical chemotherapy for the treatment of skin cancer. In: Rigel DS, Friedman RJ, Dzubow LM, Reintgen DS, Bystryn J-C, Marks R, Eds, Cancer of the Skin, 1st Edition. Elsevier-Saunders, Philadelphia, PA, USA. 2005, pp 619-630. Del Rosso JQ, Kim GK. Topical therapy for acne scarring. In: Tosti A, Pia De Padova M, Beer KR, Eds. Acne scars: classification and treatment, informaHealthcare, London, UK, 2010. Del Rosso JQ, Daniel III CR. Disorders of the nail. In: Dale DC, Federman DD, et al, Eds. WebMD Scientific American Medicine 2003 Edition, WebMD Professional Publishing, New York, NY, USA, 2003, pp 519-525. Del Rosso JQ, Basuk PJ, Scher RK, Ricci AR. Dermatologic diseases of the nail unit. In: Scher RK, Daniel III CR, Eds, Nails: Diagnosis, Therapy Surgery, 2nd Edition, WB Saunders Company, Philadelphia, PA, USA. 1997, pp 172-200. Articles (peer-reviewed, indexed journals) Del Rosso JQ. The role of topical antifungal therapy for onychomycosis and the emergence of newer agents. J Clin Aesthet Dermatol. 2014 Jul;7(7):10-8. Del Rosso JQ, Kircik LH. Transitioning from brand to generic with topical products and

the importance of maintaining the formulation and therapeutic profiles of the original

product: focus on clocortolone pivalate 0.1% cream. J Drugs Dermatol. 2014

Jul;13(7):s77-83.

Levin J, Fallon Friedlander S, Del Rosso JQ. Atopic dermatitis and the stratum corneum:

part 3: the immune system in atopic dermatitis. J Clin Aesthet Dermatol. 2013

Dec;6(12):37-44.

Levin J, Friedlander SF, Del Rosso JQ. Atopic dermatitis and the stratum corneum: part

2: other structural and functional characteristics of the stratum corneum barrier in

atopic skin. J Clin Aesthet Dermatol. 2013 Nov;6(11):49-54.

of 31

Levin J, Friedlander SF, Del Rosso JQ. Atopic dermatitis and the stratum corneum: part

1: the role of filaggrin in the stratum corneum barrier and atopic skin. J Clin Aesthet

Dermatol. 2013 Oct;6(10):16-22.

Del Rosso JQ, Brandt S, The role of skin care as an integral component in the

management of acne vulgaris: part 2: tolerability and performance of a designated skin

care regimen using a foam wash and moisturizer SPF 30 in patients with acne vulgaris

undergoing active treatment. J Clin Aesthet Dermatol. 2013 Dec;6(12):28-36.

Del Rosso JQ. The role of skin care as an integral component in the management of acne

vulgaris: part 1: the importance of cleanser and moisturizer ingredients, design, and

product selection. J Clin Aesthet Dermatol. 2013 Dec;6(12):19-27.

Del Rosso JQ, Thiboutot D, Gallo R, Webster G, Tanghetti E, Eichenfield LF, Stein-Gold

L, Berson D, Zaenglein A. Consensus recommendations from the American Acne &

Rosacea Society on the management of rosacea, part 5: a guide on the management of

rosacea. Cutis. 2014 Mar;93(3):134-8.

Tanghetti E, Del Rosso JQ, Thiboutot D, Gallo R, Webster G, Eichenfield LF, Stein-Gold


Rosacea Society on the management of rosacea, part 4: a status report on physical

modalities and devices. Cutis. 2014 Feb;93(2):71-6.



Rosacea Society on the management of rosacea, part 3: a status report on systemic

therapies. Cutis. 2014 Jan;93(1):18-28.



Rosacea Society on the management of rosacea, part 2: a status report on topical agents.

Cutis. 2013 Dec;92(6):277-84



Rosacea Society on the management of rosacea, part 1: a status report on the disease

state, general measures, and adjunctive skin care. Cutis. 2013 Nov;92(5):234-40.

Leyden JJ, Del Rosso JQ, Baum EW. The use of isotretinoin in the treatment of acne

vulgaris: clinical considerations and future directions. J Clin Aesthet Dermatol. 2014

Feb;7(2 Suppl):S3-S21.

of 31

Del Rosso JQ, Plattner JJ. From the Test Tube to the Treatment Room: Fundamentals of

Boron-containing Compounds and their Relevance to Dermatology. J Clin Aesthet

Dermatol. 2014 Feb;7(2):13-21.

Del Rosso JQ. Incorporation of a barrier protection cream in the management of chronic

hand dermatitis: focus on data supporting an established hand protectant formulation

and modifications designed to assist in barrier repair. J Clin Aesthet Dermatol. 2014

Feb;7(2):40-8.

Del Rosso JQ, Zeichner J. What's New in the Medicine Cabinet?: A Panoramic Review of

Clinically Relevant Information for the Busy Dermatologist. J Clin Aesthet Dermatol.

2014 Jan;7(1):26-30.

Two AM, Del Rosso JQ. Kallikrein 5-mediated inflammation in rosacea: clinically

relevant correlations with acute and chronic manifestations in rosacea and how

individual treatments may provide therapeutic benefit. J Clin Aesthet Dermatol. 2014

Jan;7(1):20-5.

Del Rosso JQ, Kircik LH. Optimizing topical antifungal therapy for superficial

cutaneous fungal infections: focus on topical naftifine for cutaneous dermatophytosis. J

Drugs Dermatol. 2013 Nov;12(11 Suppl):s165-71.

Del Rosso JQ, Cash K. Topical corticosteroid application and the structural and

functional integrity of the epidermal barrier. J Clin Aesthet Dermatol. 2013

Nov;6(11):20-7.

Kircik L, Lebwohl MG, Del Rosso JQ, Bagel J, Stein Gold L, Weiss JS. Clinical study

results of desoximetasone spray, 0.25% in moderate to severe plaque psoriasis. J Drugs

Dermatol. 2013 Dec;12(12):1404-10.

Del Rosso JQ. Management of facial erythema of rosacea: what is the role of topical α-

adrenergic receptor agonist therapy? J Am Acad Dermatol. 2013 Dec;69(6 Suppl 1):S44-

56.

Del Rosso JQ, Kircik LH. The sequence of inflammation, relevant biomarkers, and the

pathogenesis of acne vulgaris: what does recent research show and what does it mean

to the clinician? J Drugs Dermatol. 2013 Aug;12(8 Suppl):s109-15.

Lebwohl MG, Del Rosso JQ, Abramovits W, Berman B, Cohen DE, Guttman E, Mancini

AJ, Schachner LA. Pathways to managing atopic dermatitis: consensus from the experts.

J Clin Aesthet Dermatol. 2013 Jul;6(7 Suppl):S2-S18.

Del Rosso JQ, Kircik LH. The integration of physiologically-targeted skin care in the

management of atopic dermatitis: focus on the use of a cleanser and moisturizer system

of 31

incorporating a ceramide precursor, filaggrin degradation products, and specific "skin-

barrier-friendly" excipients. J Drugs Dermatol. 2013 Jul 1;12(7):s85-91.

Del Rosso JQ. Application of protease technology in dermatology: rationale for

incorporation into skin care with initial observations on formulations designed for skin

cleansing, maintenance of hydration, and restoration of the epidermal permeability

barrier. J Clin Aesthet Dermatol. 2013 Jun;6(6):14-22.

Coda AB, Hata T, Miller J, Audish D, Kotol P, Two A, Shafiq F, Yamasaki K, Harper JC,

Del Rosso JQ, Gallo RL. Cathelicidin, kallikrein 5, and serine protease activity is

inhibited during treatment of rosacea with azelaic acid 15% gel. J Am Acad Dermatol.

2013 Oct;69(4):570-7.

Del Rosso JQ. Clinical relevance of skin barrier changes associated with the use of oral

isotretinoin: the importance of barrier repair therapy in patient management. J Drugs

Dermatol. 2013 Jun 1;12(6):626-31.

Del Rosso JQ, Gallo RL, Tanghetti E, Webster G, Thiboutot D. An evaluation of

potential correlations between pathophysiologic mechanisms, clinical manifestations,

and management of rosacea. Cutis. 2013 Mar;91(3 Suppl):1-8.

Del Rosso JQ, Reece B, Smith K, Miller T. Efinaconazole 10% solution: a new topical

treatment for onychomycosis: contact sensitization and skin irritation potential. J Clin

Aesthet Dermatol. 2013 Mar;6(3):20-4.

Del Rosso JQ, Tanghetti E. A status report on topical tazarotene in the management of

acne vulgaris. J Drugs Dermatol. 2013 Mar;12(3):s53-8.

Kim GK, Del Rosso JQ. Topical pimecrolimus 1% cream in the treatment of seborrheic

dermatitis. J Clin Aesthet Dermatol. 2013 Feb;6(2):29-35.

Thiboutot D, Del Rosso JQ. Acne vulgaris and the epidermal barrier: Is acne vulgaris

associated with inherent epidermal abnormalities that cause impairment of barrier

functions? Do any topical acne therapies alter the structural and/or functional integrity

of the epidermal barrier? J Clin Aesthet Dermatol. 2013 Feb;6(2):18-24.

Del Rosso JQ, Kircik LH. The role of a midpotency topical corticosteroid and the clinical

relevance of formulation characteristics in the management of commonly encountered

eczematous and inflammatory dermatoses in adults and children: focus on the

pharmacologic properties of clocortolone pivalate 0.1% cream. J Drugs Dermatol. 2013

Feb;12(2):s5-s10.

Winkelmann RR, Kim GK, Del Rosso JQ. Treatment of cutaneous lupus erythematosus:

review and assessment of treatment benefits based on Oxford Centre for Evidence-

based Medicine Criteria. J Clin Aesthet Dermatol. 2013 Jan;6(1):27-38.

of 31

Del Rosso JQ, Kircik LH. Not all topical corticosteroids are created equal! optimizing

therapeutic outcomes through better understanding of vehicle formulations, compound

selection,and methods of application. J Drugs Dermatol. 2012 Dec;11(12):s5-8.

Del Rosso JQ. Face to face with oral isotretinoin: a closer look at the spectrum of

therapeutic outcomes and why some patients need repeated courses. J Clin Aesthet

Dermatol. 2012 Nov;5(11):17-24.

Kircik LH, Del Rosso JQ. The treatment of inflammatory facial dermatoses with topical

corticosteroids: focus on clocortolone pivalate 0.1% cream. J Drugs Dermatol. 2012

Oct;11(10):1194-8.

Del Rosso JQ, Kircik L. A comprehensive review of clocortolone pivalate 0.1% cream:

structural development, formulation characteristics, and studies supporting treatment

of corticosteroid-responsive dermatoses. J Clin Aesthet Dermatol. 2012 Jul;5(7):20-4.

Tan J, Wolfe B, Weiss J, Stein-Gold L, Bikowski J, Del Rosso J, Webster GF, Lucky A,

Thiboutot D, Wilkin J, Leyden J, Chren MM. Acne severity grading: determining

essential clinical components and features using a Delphi consensus. J Am Acad

Dermatol. 2012 Aug;67(2):187-93.

Bhatia ND, Del Rosso JQ. Optimal management of papulopustular rosacea: rationale for

combination therapy. J Drugs Dermatol. 2012 Jul;11(7):838-44.

Leyden JJ, Del Rosso JQ. The effect of benzoyl peroxide 9.8% emollient foam on

reduction of Propionibacterium acnes on the back using a short contact therapy approach.

J Drugs Dermatol. 2012 Jul;11(7):830-3.

Del Rosso JQ, Preston NJ, Caveney SW, Gottschalk RW. Effectiveness and safety of

modified-release doxycycline capsules once daily for papulopustular rosacea

monotherapy results from a large community-based trial in subgroups based on

gender. J Drugs Dermatol. 2012 Jun;11(6):703-7.

Del Rosso JQ, Gallo RL, Kircik L, Thiboutot D, Baldwin HE, Cohen D. Why is rosacea

considered to be an inflammatory disorder? The primary role, clinical relevance, and

therapeutic correlations of abnormal innate immune response in rosacea-prone skin.

J Drugs Dermatol. 2012 Jun;11(6):694-700.

Kim GK, Del Rosso JQ. Oral spironolactone in post-teenage female patients with acne

vulgaris: practical considerations for the clinician based on current data and clinical

experience. J Clin Aesthet Dermatol. 2012 Mar;5(3):37-50.

Del Rosso JQ. Advances in understanding and managing rosacea: part 2: the central

role, evaluation, and medical management of diffuse and persistent facial erythema of

rosacea. J Clin Aesthet Dermatol. 2012 Mar;5(3):26-36.

of 31

Del Rosso JQ. Advances in understanding and managing rosacea: part 1: connecting the

dots between pathophysiological mechanisms and common clinical features of rosacea

with emphasis on vascular changes and facial erythema. J Clin Aesthet Dermatol. 2012

Mar;5(3):16-25.

Michaels BD, Del Rosso JQ. Tinea capitis in infants: recognition, evaluation, and

management suggestions. J Clin Aesthet Dermatol. 2012 Feb;5(2):49-59.

Del Rosso JQ, Harper J, Pillai R, Moore R. Tretinoin photostability: comparison of

micronized tretinoin (0.05%) gel and tretinoin (0.025%) gel following exposure to

ultraviolet a light. J Clin Aesthet Dermatol. 2012 Jan;5(1):27-9.

Kircik LH, Del Rosso JQ. Nonsteroidal treatment of atopic dermatitis in pediatric

patients with a ceramide-dominant topical emulsion formulated with an optimized

ratio of physiological lipids. J Clin Aesthet Dermatol. 2011 Dec;4(12):25-31.

Del Rosso JQ, Levin J. Clinical relevance of maintaining the structural and functional

integrity of the stratum corneum: why is it important to you? J Drugs Dermatol. 2011

Oct;10(10 Suppl):s5-12.

Park H, Del Rosso JQ. Use of oral isotretinoin in the management of rosacea. J Clin

Aesthet Dermatol. 2011 Sep;4(9):54-61.

Del Rosso JQ, Levin J. The clinical relevance of maintaining the functional integrity of

the stratum corneum in both healthy and disease-affected skin. J Clin Aesthet Dermatol.

2011 Sep;4(9):22-42.

Del Rosso JQ, Bhatia N. Azelaic acid gel 15% in the management of papulopustular

rosacea: a status report on available efficacy data and clinical application. Cutis. 2011

Aug;88(2):67-72.

Ritvo E, Del Rosso JQ, Stillman MA, La Riche C. Psychosocial judgements and

perceptions of adolescents with acne vulgaris: A blinded, controlled comparison of

adult and peer evaluations. Biopsychosoc Med. 2011 Aug 13;5(1):11.

Del Rosso JQ. Management of papulopustular rosacea and perioral dermatitis with

emphasis on iatrogenic causation or exacerbation of inflammatory facial dermatoses:

use of doxycycline-modified release 40 mg capsule once daily in combination with

properly selected skin care as an effective approach. J Clin Aesthet Dermatol. 2011

Aug;4(8):20-30.

Del Rosso JQ. Current regimens and guideline implications for the treatment of actinic

keratosis: proceedings of a clinical roundtable at the 2011 Winter Clinical Dermatology

Conference. Cutis. 2011 Jul;88(1):suppl 1-8.

of 31

Del Rosso JQ. Repair and maintenance of the epidermal barrier in patients diagnosed

with atopic dermatitis: an evaluation of the components of a body wash-moisturizer

skin care regimen directed at management of atopic skin. J Clin Aesthet Dermatol. 2011

Jun;4(6):45-55.

Bellew S, Thiboutot D, Del Rosso JQ. Pathogenesis of acne vulgaris: what's new, what's

interesting and what may be clinically relevant. J Drugs Dermatol. 2011 Jun;10(6):582-5.

Del Rosso JQ. Adult seborrheic dermatitis: a status report on practical topical

management. J Clin Aesthet Dermatol. 2011 May;4(5):32-8.

Kircik LH, Del Rosso JQ, Aversa D. Evaluating clinical use of a ceramide-dominant,

physiologic lipid-based topical emulsion for atopic dermatitis. J Clin Aesthet Dermatol.

2011 Mar;4(3):34-40.

Kim GK. Del Rosso JQ. Status report on the management of dermatofibrosarcoma

protuberans: is there a viable role for the use of imatinib mesylate? In which cases may

it be therapeutically helpful and in which cases not? J Clin Aesthet Dermatol.

2011 Mar;4(3):17-26.

Del Rosso JQ. Wound care in the dermatology office: where are we in 2011? J Am Acad

Dermatol. 2011 Mar;64(3 Suppl):S1-7.

Leyden JJ, Del Rosso JQ. Oral antibiotic therapy for acne vulgaris: pharmacokinetic and

pharmacodynamic perspectives. J Clin Aesthet Dermatol. 2011 Feb;4(2):40-7.

Del Rosso JQ. Effectiveness and safety of doxycycline 40 mg (30-mg immediate-release

and 10-mg delayed-release beads) once daily as add-on therapy to existing topical

regimens for the treatment of papulopustular rosacea: results from a community-based

trial. Cutis. 2010 Nov;86(5 Suppl):16-25.

Zeichner JA, Lebwohl MG, Menter A, Bagel J, Del Rosso JQ, Elewski BE, Feldman SR,

Kircik LH, Koo J, Gold LS, Tanghetti E; Psoriasis Process of Care Consensus Panel.

Optimizing topical therapies for treating psoriasis: a consensus conference. Cutis.

2010 Sep;86(3 Suppl):5-31.

Del Rosso JQ, Pillai R, Moore R. Absence of degradation of tretinoin when benzoyl

peroxide is combined with an optimized formulation of tretinoin gel (0.05%). J Clin

Aesthet Dermatol. 2010 Oct;3(10):26-8.

Kim GK. Del Rosso JQ. The rationale behind topical vitamin D analogs in the treatment

of psoriasis: where does topical calcitriol fit in? J Clin Aesthet Dermatol. 2010

Aug;3(8):46-53.

of 31

Kim GK, Del Rosso JQ. Laser and light-based therapies for acne vulgaris: a current

guide based on available data. J Drugs Dermatol. 2010 Jun;9(6):614-21.

Momin SB, Peterson A, Del Rosso JQ. A status report on drug-associated acne and

acneiform eruptions. J Drugs Dermatol. 2010 Jun;9(6):627-36.

Del Rosso JQ, Bruce S, Jarratt M, Menter A, Staedtler G. Efficacy of topical azelaic acid

(AzA) gel 15% plus oral doxycycline 40 mg versus metronidazole gel 1% plus oral

doxycycline 40 mg in mild-to-moderate papulopustular rosacea. J Drugs Dermatol. 2010

Jun;9(6):607-13.

Tanghetti E, Dhawan S, Green L, Del Rosso J, Draelos Z, Leyden J, Shalita A, Glaser DA, Grimes P, Webster G, Barnett P, Le Gall N. Randomized comparison of the safety and efficacy of tazarotene 0.1% cream and adapalene 0.3% gel in the treatment of patients with at least moderate facial acne vulgaris. J Drugs Dermatol. 2010 May;9(5):549-58. J Clin Aesthet Dermatol. 2010 Apr;3(4):49-54. Kim GK, Del Rosso JQ. The risk of fluoroquinolone-induced tendinopathy and tendon

rupture: what does the clinician need to know? J Clin Aesthet Dermatol. 2010

Apr;3(4):49-54.

Kircik L, Del Rosso JQ. Comparative efficacy and safety results of topical hemostatic

powder and sterile compressed foam sponge in second intention healing following

Mohs micrographic surgery. J Drugs Dermatol. 2010 Feb;9(2):137-40.

Kim GK, Del Rosso JQ. Drug-provoked psoriasis: is it drug induced or drug

aggravated?: understanding pathophysiology and clinical relevance. J Clin Aesthet

Dermatol. 2010 Jan;3(1):32-8.

Del Rosso JQ, Schmidt NF. A review of the anti-inflammatory properties of clindamycin

in the treatment of acne vulgaris. Cutis. 2010 Jan;85(1):15-24.

Michaels BD, Del Rosso JQ, Momin SB. Avoiding the legal "blemish": medicolegal

pitfalls in dermatology. J Clin Aesthet Dermatol. 2009 Dec;2(12):35-43.

Del Rosso JQ. Perspectives on seborrheic dermatitis: looking back to move ahead. Clin

Dermatol. 2009 Nov-Dec;27(6 Suppl):S39-40.

Kim GK. Del Rosso JQ. Seborrheic dermatitis and Malassezia species: how are they

related. J Clin Aesthet Dermatol. 2009 Nov;2(11):14-7.

Bellew S, Del Rosso JQ, Kim GK. Skin cancer in asians: part 2: melanoma. J Clin Aesthet

Dermatol. 2009 Oct;2(10):34-6.

Del Rosso JQ, Kim GK. Topical antibiotics: therapeutic value or ecologic mischief?

Dermatol Ther. 2009 Sep-Oct;22(5):398-406.

of 31

Del Rosso JQ, Bhambri S. Daily application of fluocinonide 0.1% cream for the treatment

of atopic dermatitis. J Clin Aesthet Dermatol. 2009 Sep;2(9):24-32.

Kim GK, Del Rosso JQ, Bellew S. Skin cancer in asians: part 1: nonmelanoma skin

cancer. J Clin Aesthet Dermatol. 2009 Aug;2(8):39-42.

Bellew S, Del Rosso JQ, Mobini N. Primary carcinosarcoma of the ear: case report and

review of the literature. J Clin Aesthet Dermatol. 2009 Aug;2(8):33-5.

Del Rosso JQ. The use of moisturizers as an integral component of topical therapy for

rosacea: clinical results based on the Assessment of Skin Characteristics Study. Cutis.

2009 Aug;84(2):72-6.

Del Rosso JQ. A 6% benzoyl peroxide foaming cloth cleanser used in the treatment of

acne vulgaris: aesthetic characteristics, patient preference considerations, and impact on

compliance with treatment. J Clin Aesthet Dermatol. 2009 Jul;2(7):26-9.

Del Rosso JQ. Anti-inflammatory dose doxycycline in the treatment of rosacea. J Drugs

Dermatol. 2009 Jul;8(7):664-8.

Thiboutot DM, Fleischer AB, Del Rosso JQ, Rich P. A multicenter study of topical

azelaic acid 15% gel in combination with oral doxycycline as initial therapy and azelaic

acid 15% gel as maintenance monotherapy. J Drugs Dermatol. 2009 Jul;8(7):639-48.

Thiboutot D, Eichenfield L, Shalita A, Del Rosso JQ, Swinyer L, Tanghetti E, Tschen E,

Parr LA. 3-step acne system containing solubilized benzoyl peroxide versus

clindamycin-benzoyl peroxide. Cutis. 2009 Jul;84(1):48-55.

Bhambri S, Del Rosso JQ, Bhambri A. Pathogenesis of acne vulgaris: recent advances. J

Drugs Dermatol. 2009 Jul;8(7):615-8.

Del Rosso JQ, Baldwin H, Keri J, Mancini A, Gold LS, Webster GF. Current approach to

acne management: a community-based analysis. Cutis. 2009 Jun;83(6 Suppl):5-21.

Momin SB1, Del Rosso JQ, Michaels B, Mobini N. Acute generalized exanthematous

pustulosis: an enigmatic drug-induced reaction. Cutis. 2009 Jun;83(6):291-8.

Kircik LH, Del Rosso JQ. Anti-TNF agents for the treatment of psoriasis. J Drugs

Dermatol. 2009 Jun;8(6):546-59.

Del Rosso JQ, Sofen H, Leshin B, Meng T, Kulp J, Levy S. Safety and efficacy of multiple

16-week courses of topical imiquimod for the treatment of large areas of skin involved

with actinic keratoses. J Clin Aesthet Dermatol. 2009 Apr;2(4):20-8.

Del Rosso JQ, Lehman PA, Raney SG, Impact of order of application of moisturizers on

percutaneous absorption kinetics: evaluation of sequential application of moisturizer

of 31

lotions and azelaic acid gel 15% using a human skin model. Cutis. 2009 Mar;83(3):119-

24.

Momin SB, Richardson BS, Bryan MG, Del Rosso JQ, Mobini N. Mycetoma clinically

masquerading as squamous cell carcinoma: case report and literature review. J Clin

Aesthet Dermatol. 2009 Feb;2(2):26-31.

Del Rosso JQ, Kim G. Optimizing use of oral antibiotics in acne vulgaris. Dermatol Clin.

2009 Jan;27(1):33-42.

Bhambri S, Bhambri A, Del Rosso JQ. Atypical mycobacterial cutaneous infections.

Dermatol Clin. 2009 Jan;27(1):63-73.

Del Rosso JQ. Oral antibiotic drug interactions of clinical significance to dermatologists.

Dermatol Clin. 2009 Jan;27(1):91-4.

Bikowski JB, Del Rosso JQ. Demodex dermatitis: a retrospective analysis of clinical

diagnosis and successful treatment with topical crotamiton. J Clin Aesthet Dermatol.

2009 Jan;2(1):20-5.

Leyden JJ, Del Rosso JQ, Webster GF. Clinical considerations in the treatment of acne

vulgaris and other inflammatory skin disorders: a status report. Dermatol Clin. 2009

Jan;27(1):1-15.

Del Rosso JQ. Benzoyl peroxide cleansers for the treatment of acne vulgaris: status

report on available data. Cutis. 2008 Nov;82(5):336-42.

Del Rosso JQ. Selection of therapy for acne vulgaris: balancing concerns about antibiotic

resistance. Cutis. 2008 Nov;82(5 Suppl):12-6.

Del Rosso JQ. Update from the Scientific Panel on Antibiotic Use in Dermatology:

clinical considerations for the dermatologist. Cutis. 2008 Aug;82(2 Suppl 2):3-4.

Del Rosso JQ1, Leyden JJ, Thiboutot D, Webster GF. Antibiotic use in acne vulgaris and

rosacea: clinical considerations and resistance issues of significance to dermatologists.

Cutis. 2008 Aug;82(2 Suppl 2):5-12.

Del Rosso JQ. Comprehensive management of patients with superficial fungal

infections: the role of sertaconazole nitrate. Cutis. 2008 Jun;81(6 Suppl):4-18.

Del Rosso JQ, Schlessinger J, Werschler P. Comparison of anti-inflammatory dose

doxycycline versus doxycycline 100 mg in the treatment of rosacea. J Drugs Dermatol.

2008 Jun;7(6):573-6.

Thiboutot DM, Fleischer AB Jr, Del Rosso JQ, Graupe K. Azelaic acid 15% gel once daily

versus twice daily in papulopustular rosacea. J Drugs Dermatol. 2008 Jun;7(6):541-6.

of 31

Del Rosso JQ, Baldwin H, Webster G; American Acne & Rosacea Society. American

Acne & Rosacea Society rosacea medical management guidelines. J Drugs Dermatol.

2008 Jun;7(6):531-3.

Del Rosso JQ, Jitpraphai W, Bhambri S, Momin S. Clindamycin phosphate 1.2%-

tretinoin 0.025% gel: vehicle characteristics, stability, and tolerability. Cutis. 2008

May;81(5):405-8.

Bhambri S, Desai A, Del Rosso JQ, Mobini N. Dermatofibrosarcoma protuberans: a case

report and review of the literature. J Clin Aesthet Dermatol. 2008 May;1(1):34-6.

Del Rosso JQ, Baum EW. Comprehensive medical management of rosacea: an interim

study report and literature review. J Clin Aesthet Dermatol. 2008 May;1(1):20-5.

Romanowicz M, Stephenson JJ, Del Rosso JQ, Lenhart G. Healthcare utilization and

costs of patients with rosacea in an insured population. J Drugs Dermatol. 2008

Jan;7(1):41-9.

Del Rosso JQ. Newer topical therapies for the treatment of acne vulgaris. Cutis. 2007

Nov;80(5):400-10.

Del Rosso JQ. Recently approved systemic therapies for acne vulgaris and rosacea. Cutis. 2007

Aug;80(2):113-20.

Bhambri S, Del Rosso JQ, Desai A. Oral trimethoprim/sulfamethoxazole in the treatment of

acne vulgaris. Cutis. 2007 Jun;79(6):430-4.

Del Rosso JQ. Study results of benzoyl peroxide 5%/clindamycin 1% topical gel, adapalene

0.1% gel, and use in combination for acne vulgaris. J Drugs Dermatol. 2007 Jun;6(6):616-22.

Del Rosso JQ, Bikowski JB, Baum E, Smith J, Hawkes S, Benes V, Bhatia N. A closer look at

truncal acne vulgaris: prevalence, severity, and clinical significance. J Drugs Dermatol. 2007

Jun;6(6):597-600.

Leyden JJ, Del Rosso JQ, Webster GF. Clinical considerations in the treatment of acne vulgaris

and other inflammatory skin disorders: focus on antibiotic resistance. Cutis. 2007 Jun;79(6

Suppl):9-25.

Del Rosso JQ, Elston DM. Tackling the anterior nares and other sites of colonization:

implications for the dermatologist. Cutis. 2007 Jun;79(6 Suppl):52-9.

Del Rosso JQ, Webster GF, Jackson M, Rendon M, Rich P, Torok H, Bradshaw M. Two

randomized phase III clinical trials evaluating anti-inflammatory dose doxycycline (40-mg

doxycycline, USP capsules) administered once daily for treatment of rosacea. J Am Acad

Dermatol. 2007 May;56(5):791-802.

Del Rosso JQ. The treatment of viral infections and nonmelanoma skin cancers. Cutis. 2007

Apr;79(4 Suppl):29-35.

of 31

Desai A, Kartono F, Del Rosso JQ. Systemic retinoid therapy: a status report on optimal use and

safety of long-term therapy. Dermatol Clin. 2007 Apr;25(2):185-93.

Webster G, Del Rosso JQ. Anti-inflammatory activity of tetracyclines. Dermatol Clin. 2007

Apr;25(2):133-

Del Rosso JQ, Leyden JJ. Status report on antibiotic resistance: implications for the

dermatologist. Dermatol Clin. 2007 Apr;25(2):127-32.

Del Rosso JQ, Draelos ZD, Jorizzo JL, Joseph WS, Ribotsky BM, Rich P. Modern methods to treat

superficial fungal disease. Cutis. 2007 Feb;79(2 Suppl):6-29.

Wolf JE Jr, Del Rosso JQ, The CLEAR trial: results of a large community-based study of

metronidazole gel in rosacea. Cutis. 2007 Jan;79(1):73-80.

Del Rosso JQ. Defining criteria used to evaluate response to treatment of acne vulgaris. Cutis.

2006 Aug;78(2):117-21.

Del Rosso JQ. Update on rosacea pathogenesis and correlation with medical therapeutic agents.

Cutis. 2006 Aug;78(2):97-100.

Del Rosso JQ. Combination topical therapy in the treatment of acne. Cutis. 2006 Aug;78(2 Suppl

1):5-12.

Ceilley RI, Del Rosso JQ. Current modalities and new advances in the treatment of basal cell

carcinoma. Int J Dermatol. 2006 May;45(5):489-98.

Del Rosso JQ. Clinical significance of brand versus generic formulations: focus on oral

minocycline. Cutis. 2006 Mar;77(3):153-6.

Del Rosso JQ. The use of topical azelaic acid for common skin disorders other than

inflammatory rosacea. Cutis. 2006 Feb;77(2 Suppl):22-4.

Del Rosso JQ, Tanghetti E. The clinical impact of vehicle technology using a patented

formulation of benzoyl peroxide 5%/clindamycin 1% gel: comparative assessments of skin

tolerability and evaluation of combination use with a topical retinoid. J Drugs Dermatol. 2006

Feb;5(2):160-4.

Del Rosso JQ. The use of topical imiquimod for the treatment of actinic keratosis: a status report.

Cutis. 2005 Oct;76(4):241-8.

Del Rosso JQ. A qualitative and quantitative assessment of the application and use of topical

acne medication by patients. Cutis. 2005 Aug;76(2):109-13.

Del Rosso JQ, Bikowski J. Topical metronidazole combination therapy in the clinical

management of rosacea. J Drugs Dermatol. 2005 Jul-Aug;4(4):473-80.

Del Rosso JQ. Antibiotic resistance: overview and significance in dermatology. Cutis. 2005

Apr;75(4 Suppl):12-8.

of 31

Del Rosso JQ. Adjunctive skin care in the management of rosacea: cleansers, moisturizers, and

photoprotectants. Cutis. 2005 Mar;75(3 Suppl):17-21.

Del Rosso JQ. A status report on the use of subantimicrobial-dose doxycycline: a review of the

biologic and antimicrobial effects of the tetracyclines. Cutis. 2004 Aug;74(2):118-22.

Del Rosso JQ. Medical treatment of rosacea with emphasis on topical therapies. Expert Opin

Pharmacother. 2004 Jan;5(1):5-13.

Del Rosso JQ. Evaluating the role of topical therapies in the management of rosacea: focus on

combination sodium sulfacetamide and sulfur formulations. Cutis. 2004 Jan;73(1 Suppl):29-33.

Del Rosso JQ. New and emerging topical approaches for actinic keratoses. Cutis. 2003

Oct;72(4):273-6, 279.

Del Rosso JQ. Oral cephalosporin antibiotics: an overview of clinical pharmacology and

dermatologic applications. Cutis. 2003 Feb;71(2):153-7.

Del Rosso JQ. An update on newer topical therapies for actinic keratoses: advances and

applications. J Drugs Dermatol. 2003 Jan;2(1):35-9.

Del Rosso JQ. Cephalosporins in dermatology. Clin Dermatol. 2003 Jan-Feb;21(1):24-32.

Del Rosso JQ. A status report on the medical management of rosacea: focus on topical therapies.

Cutis. 2002 Nov;70(5):271-5.

Del Rosso JQ. Retinoic acid receptors and topical acne therapy: establishing the link between

gene expression and drug efficacy. Cutis. 2002 Aug;70(2):127-9.

Del Rosso JQ. Skin manifestations of drug reactions. Curr Allergy Asthma Rep. 2002

Jul;2(4):282-7.

Del Rosso JQ. Systemic therapy for rosacea: focus on oral antibiotic therapy and safety. Cutis.

2000 Oct;66(4 Suppl):7-13.

Del Rosso JQ. Current management of onychomycosis and dermatomycoses. Curr Infect Dis

Rep. 2000 Oct;2(5):438-445.

Gupta AK, Del Rosso JQ. An evaluation of intermittent therapies used to treat onychomycosis

and other dermatomycoses with the oral antifungal agents. Int J Dermatol. 2000 Jun;39(6):401-

11.

Del Rosso JQ, Gupta AK. The use of intermittent itraconazole therapy for superficial mycotic

infections: a review and update on the 'one week' approach. Int J Dermatol. 1999 Sep;38 Suppl

2:28-39.

Del Rosso JQ, Gupta AK. Management of tinea capitis. A status report. Postgrad Med. 1999

Jul;Spec No:38-45.

Gupta AK, Chang P, Del Rosso JQ, Adam P, Hofstader SL. Onychomycosis in children:

prevalence and management. Pediatr Dermatol. 1998 Nov-Dec;15(6):464-71.

of 31

Del Rosso JQ, Zellis S, Gupta AK. Itraconazole in the treatment of superficial cutaneous and

mucosal Candida infections. J Am Osteopath Assoc. 1998 Sep;98(9):497-502.

Gupta AK, Del Rosso JQ, Lynde CW, Brown GH, Shear NH. Hepatitis associated with

terbinafine therapy: three case reports and a review of the literature. Clin Exp Dermatol.

1998 Mar;23(2):64-7.

Del Rosso JQ. Advances in the treatment of superficial fungal infections: focus on

onychomycosis and dry tinea pedis. J Am Osteopath Assoc. 1997 Jun;97(6):339-46.

Del Rosso JQ. Treatment of onychomycosis and tinea pedis with intermittent itraconazole

therapy. J Am Osteopath Assoc. 1996 Oct;96(10):607-9.

Geiss DF, Del Rosso JQ, Murphy J. Verruciform xanthoma of the glans penis: a benign clinical

simulant of genital malignancy. Cutis. 1993 May;51(5):369-72.

Del Rosso JQ. Treatment of Darier's disease with isotretinoin: report of a case. J Am Osteopath

Assoc. 1986 Oct;86(10):634-8.

Recognitions and Awards

Gold Triangle Award American Academy of Dermatology Chicago, Illinois Co-Author: “ Rosacea Roadmap” July 21, 2005 Gold Triangle Award American Academy of Dermatology New York, New York Author: “Spotlight on Inflammatory Acne” Skin & Aging, August 2003, HMP Communications (Publisher) July 31, 2004 Outstanding Teacher Award Society of Dermatology Physician Assistants Las Vegas Local Region Las Vegas, Nevada 2003 Outstanding Teacher Award Ohio University College of Osteopathic Medicine Athens, Ohio 1990

of 31

Outstanding Faculty Award Southeast Ohio Region Ohio University College of Osteopathic Medicine Athens, Ohio 1989 Edmund D Lowney MD Resident Clinical Instructor Teaching Award Ohio State University Section of Dermatology Columbus, Ohio 1989, 1990 Office of Patient Relations Patient Education Award Ohio University Osteopathic Medical Center Athens, Ohio 1989 Daniel C Koprince DO Outstanding Lecture Award American Osteopathic College of Dermatology Atlanta, Georgia 1989

JAMES Q. DEL ROSSO, DO, FAOCD

January 4, 2016

JDR/ab

james q. del rosso, do, faocd

Documents